Entrada Therapeutics (TRDA) Receivables (2023 - 2026)
Entrada Therapeutics' Receivables came in at $816,000 for Q2 2026, down 30.8% from $1.18 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Receivables (2023 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics' Receivables was $1.18 million, down 68.0% from FY2024.
- Going back by year, Receivables was $3.68 million in FY2024 (-37.4%) and $5.88 million in FY2023.
- The five-year range for quarterly Receivables is $787,000 (Q1 2026) to $77.51 million (Q1 2024).
- Year-over-year, Receivables has declined for eight consecutive quarters, with an average decline of 60.2% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q2 2024 (growth of 105.0%), and the weakest in Q1 2025 (a decline of 97.4%).
- Business Quant data shows TRDA's Receivables at $787,000 (Q1 2026), $1.18 million (Q4 2025) and $1.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Entrada Therapeutics | 209.84 Mn | -149.56 Mn | - | 816,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 816,000.00 |
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 77.51 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 3.74 Mn |
| Mar 31, 2023 | 6.30 Mn |
API Access
Entrada Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();